517 related articles for article (PubMed ID: 15736420)
21. Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa.
Herath NI; Walsh MD; Kew MC; Young J; Leggett BA; Macdonald GA
J Gastroenterol Hepatol; 2004 Jun; 19(6):676-82. PubMed ID: 15151624
[TBL] [Abstract][Full Text] [Related]
22. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
Chetty R; Serra S; Asa SL
Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
[TBL] [Abstract][Full Text] [Related]
23. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
Sarrió D; Moreno-Bueno G; Sánchez-Estévez C; Bañón-Rodríguez I; Hernández-Cortés G; Hardisson D; Palacios J
Hum Pathol; 2006 Aug; 37(8):1042-9. PubMed ID: 16867867
[TBL] [Abstract][Full Text] [Related]
24. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
[TBL] [Abstract][Full Text] [Related]
25. Altered gamma-catenin expression correlates with poor survival in patients with bladder cancer.
Syrigos KN; Harrington K; Waxman J; Krausz T; Pignatelli M
J Urol; 1998 Nov; 160(5):1889-93. PubMed ID: 9783980
[TBL] [Abstract][Full Text] [Related]
26. Reduced expression of molecules of the cadherin/catenin complex in the transition from colorectal adenoma to carcinoma.
Hao X; Palazzo JP; Ilyas M; Tomlinson I; Talbot IC
Anticancer Res; 1997; 17(3C):2241-7. PubMed ID: 9216695
[TBL] [Abstract][Full Text] [Related]
27. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis.
Karayiannakis AJ; Syrigos KN; Polychronidis A; Simopoulos C
Anticancer Res; 2001; 21(6A):4127-34. PubMed ID: 11911306
[TBL] [Abstract][Full Text] [Related]
28. Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma.
Scholten AN; Creutzberg CL; van den Broek LJ; Noordijk EM; Smit VT
J Pathol; 2003 Nov; 201(3):460-5. PubMed ID: 14595758
[TBL] [Abstract][Full Text] [Related]
29. [Correlation among expression of E-cadherin, beta-catenin, and cyclin D1 in breast cancers].
Yang JF; Chen SL; Liu ZH; Zhang Y
Ai Zheng; 2004 Jul; 23(7):799-802. PubMed ID: 15248915
[TBL] [Abstract][Full Text] [Related]
30. Beta- and gamma-catenin expression in oral squamous cell carcinomas.
Lo Muzio L; Staibano S; Pannone G; Grieco M; Mignogna MD; Cerrato A; Testa NF; De Rosa G
Anticancer Res; 1999; 19(5B):3817-26. PubMed ID: 10628318
[TBL] [Abstract][Full Text] [Related]
31. [Correlation of E-cadherin, beta-catenin and gamma-catenin gene expression with the invasion and metastasis of gastric carcinoma].
Wang CX; Chen J; Yang Z; Song W; Du ZL; Li ZH
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1198-201. PubMed ID: 14625188
[TBL] [Abstract][Full Text] [Related]
32. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.
Prange W; Breuhahn K; Fischer F; Zilkens C; Pietsch T; Petmecky K; Eilers R; Dienes HP; Schirmacher P
J Pathol; 2003 Oct; 201(2):250-9. PubMed ID: 14517842
[TBL] [Abstract][Full Text] [Related]
33. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs.
Margulis A; Zhang W; Alt-Holland A; Crawford HC; Fusenig NE; Garlick JA
Cancer Res; 2005 Mar; 65(5):1783-91. PubMed ID: 15753375
[TBL] [Abstract][Full Text] [Related]
34. E-cadherin-catenin cell-cell adhesion complex and human cancer.
Wijnhoven BP; Dinjens WN; Pignatelli M
Br J Surg; 2000 Aug; 87(8):992-1005. PubMed ID: 10931041
[TBL] [Abstract][Full Text] [Related]
35. Abnormal distribution of E-cadherin and beta-catenin in different histologic types of cancer of the uterine cervix.
Rodríguez-Sastre MA; González-Maya L; Delgado R; Lizano M; Tsubaki G; Mohar A; García-Carrancá A
Gynecol Oncol; 2005 May; 97(2):330-6. PubMed ID: 15863126
[TBL] [Abstract][Full Text] [Related]
36. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant.
Rocha AS; Soares P; Seruca R; Máximo V; Matias-Guiu X; Cameselle-Teijeiro J; Sobrinho-Simões M
J Pathol; 2001 Jul; 194(3):358-66. PubMed ID: 11439369
[TBL] [Abstract][Full Text] [Related]
37. The expression of E-cadherin and catenins in sporadic colorectal carcinoma.
El-Bahrawy MA; Poulsom R; Jeffery R; Talbot I; Alison MR
Hum Pathol; 2001 Nov; 32(11):1216-24. PubMed ID: 11727261
[TBL] [Abstract][Full Text] [Related]
38. Loss of expression of E-cadherin and beta-catenin is associated with progression of pulmonary adenocarcinoma.
Awaya H; Takeshima Y; Amatya VJ; Ishida H; Yamasaki M; Kohno N; Inai K
Pathol Int; 2005 Jan; 55(1):14-8. PubMed ID: 15660698
[TBL] [Abstract][Full Text] [Related]
39. Expression of maspin in endometrioid adenocarcinoma of endometrium.
Li HW; Leung SW; Chan CS; Yu MM; Wong YF
Oncol Rep; 2007 Feb; 17(2):393-8. PubMed ID: 17203179
[TBL] [Abstract][Full Text] [Related]
40. Beta-catenin expression in human cancers.
Takayama T; Shiozaki H; Shibamoto S; Oka H; Kimura Y; Tamura S; Inoue M; Monden T; Ito F; Monden M
Am J Pathol; 1996 Jan; 148(1):39-46. PubMed ID: 8546224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
